查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786799

NAMPT抑制剂市场:市场规模，占有率，趋势，产业分析(各分子类型，不同阶段，各给药途径，各用途，各地区)与未来预测(2025年～2034年)

NAMPT Inhibitors Market Size, Share, Trends, & Industry Analysis Report By Type of Molecule (Small Molecules and Biologics), By Phase, By Route of Administration, By Application, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，预计到 2034 年，NAMPT 抑制剂市场规模将达到 55.2 亿美元。本研究报告深入分析了当前的市场动态，并分析了未来的市场成长。

随着製药公司专注于开发针对细胞能量代谢的新疗法，NAMPT 抑制剂市场正在蓬勃发展。 NAMPT 是烟酰胺腺嘌呤二核苷酸 (NAD+) 生物合成途径中的关键酶，可支持癌细胞的生长和存活。抑制这种酵素可以限制肿瘤细胞的能量供应，使其更容易受到治疗。

正在进行的临床研究和临床前研究的进展正在推动 NAMPT 抑制剂在肿瘤治疗领域的应用。这些抑制剂正在被探索作为单一疗法和联合疗法来提高治疗效果。生物技术和製药公司日益增长的兴趣，以及对标靶抗癌药物的强有力监管支持，正在推动市场成长。

NAMPT 抑制剂市场报告重点

按分子类型划分，小分子药物凭藉其良好的药物动力学、易于配製以及在抗癌药物市场开发中确立的既定地位，在 2024 年占了市场占有率的主导地位。

按阶段划分，临床前阶段在 2024 年占了市场主导地位。这是因为大多数 NAMPT 抑制剂计画都处于早期阶段，候选化合物需要经过大量的体外和体内测试，以评估疗效、毒性和药效学特性。

按给药途径划分，静脉给药凭藉其可控的药物输送、稳定的生物利用度和快速的全身暴露，在 2024 年占了市场主导地位。

按应用划分，预计到 2034 年，血液学领域将呈现最高成长率，这得益于其在药物研发中日益扩大的作用。在治疗白血病和淋巴瘤等血癌方面，以及该领域临床研究活动的增加。

受癌症研究和早期药物研发领域大量投资的推动，北美将在2024年占全球NAMPT抑制剂市场的大部分占有率。

亚太地区是成长最快的市场，这得益于该地区不断扩大的生物技术格局以及日益深入的国际研究合作参与度。

全球主要市场参与者包括 AbbVie Inc.、Angelini Pharma S.p.A.、Antengene Therapeutics Limited、Aqualung Therapeutics Corporation、阿斯特捷利康公司、拜耳公司、勃林格殷格翰公司、Calico LLC、FORMA Therapeutics, Inc.、基因泰克公司、葛兰科史克公司、GGSK.K.

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球NAMPT抑制剂市场洞察

  • 市场概述
  • NAMPT抑制剂市场动态
    • 促进因素和机会
      • 支持性监理与融资环境
      • 全球癌症负担不断增加
    • 阻碍因素与课题
      • 毒性与安全性问题
  • PESTEL分析
  • NAMPT抑制剂市场趋势
  • 价值链分析

第5章 全球NAMPT抑制剂市场:各分子类型

  • 主要调查结果
  • 简介
  • 小分子
  • 生物製药

第6章 全球NAMPT抑制剂市场:不同阶段

  • 主要调查结果
  • 简介
  • 阶段I
  • 阶段II
  • 阶段I/II
  • 前临床

第7章 全球NAMPT抑制剂市场:各给药途径

  • 主要调查结果
  • 简介
  • 口服
  • 静脉内

第8章 全球NAMPT抑制剂市场:各用途

  • 主要调查结果
  • 简介
  • 肿瘤学
  • 血液学
  • 发炎性及代谢性疾病
  • 神经学
  • 其他

第9章 全球NAMPT抑制剂市场:各地区

  • 主要调查结果
  • 简介
    • NAMPT抑制剂市场分析:各地区，2020年～2034年
  • 北美
    • 北美:各分子类型，2020年～2034年
    • 北美:不同阶段，2020年～2034年
    • 北美:各给药途径，2020年～2034年
    • 北美:各用途，2020年～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各分子类型，2020年～2034年
    • 欧洲:各阶段，2020年～2034年
    • 欧洲:各给药途径，2020年～2034年
    • 欧洲:各用途，2020年～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各分子类型，2020年～2034年
    • 亚太地区:不同阶段，2020年～2034年
    • 亚太地区:各给药途径，2020年～2034年
    • 亚太地区:各用途，2020年～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各分子类型，2020年～2034年
    • 中东·非洲:不同阶段，2020年～2034年
    • 中东·非洲:各给药途径，2020年～2034年
    • 中东·非洲:各用途，2020年～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:各分子类型，2020-2034年
    • 南美:不同阶段，2020年～2034年
    • 南美:各给药途径，2020年～2034年
    • 南美:各用途，2020年～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第10章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第11章 企业简介

  • AbbVie Inc.
  • Angelini Pharma S.p.A.
  • Antengene Therapeutics Limited
  • Aqualung Therapeutics Corporation
  • AstraZeneca plc
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Calico LLC
  • FORMA Therapeutics, Inc.
  • Genentech, Inc.
  • GlaxoSmithKline plc(GSK plc)
  • Johnson & Johnson Services, Inc.
Product Code: PM6100

The NAMPT inhibitors market size is expected to reach USD 5.52 Billion by 2034, according to a new study by Polaris Market Research. The report "NAMPT Inhibitors Market Size, Share, Trends, & Industry Analysis Report By Type of Molecule (Small Molecules and Biologics), By Phase, By Route of Administration, By Application, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The NAMPT inhibitors market is growing as pharmaceutical companies focus on developing new therapies targeting cellular energy metabolism. NAMPT is a key enzyme in the Nicotinamide Adenine Dinucleotide (NAD+) biosynthesis pathway, which supports cancer cell growth and survival. Inhibiting this enzyme helps limit energy supply to tumor cells, making them more vulnerable to treatment.

Ongoing clinical research and preclinical advancements are driving the adoption of NAMPT inhibitors across oncology pipelines. These inhibitors are explored as both standalone and combination therapies to improve treatment response. The growing interest from biotech and pharmaceutical firms, along with supportive regulatory pathways for targeted oncology drugs, is accelerating the market growth.

NAMPT Inhibitors Market Report Highlights

Based on type of molecule, the small molecules segment dominated the market share in 2024, due to its favorable pharmacokinetics, ease of formulation, and established role in oncology drug development.

In terms of phase, the preclinical segment dominated the market in 2024. This is owing to the early stage of most NAMPT inhibitor programs, as candidates undergo extensive in vitro and in vivo testing to evaluate efficacy, toxicity, and pharmacodynamic properties.

In terms of route of administration, the intravenous (IV) administration segment dominated the market in 2024, attributed to its ability to ensure controlled drug delivery, consistent bioavailability, and rapid systemic exposure.

Based on application, the hematology segment is projected to grow at the highest rate by 2034, driven by its expanding role in the treatment of blood cancers such as leukemia and lymphoma, supported by growing clinical research activity in this area.

North America accounted for the majority share in the global NAMPT inhibitors market in 2024, due to substantial investments in oncology research and early-phase drug discovery.

Asia Pacific is the fastest growing market, driven by the expanding regional biotech landscape and greater involvement in international research collaborations.

A few global key market players include AbbVie Inc., Angelini Pharma S.p.A., Antengene Therapeutics Limited, Aqualung Therapeutics Corporation, AstraZeneca plc, Bayer AG, Boehringer Ingelheim GmbH, Calico LLC, FORMA Therapeutics, Inc., Genentech, Inc., GlaxoSmithKline plc (GSK plc), Johnson & Johnson Services, Inc., Karyopharm Therapeutics Inc., Merck & Co., Inc., and Novartis AG.

Polaris Market Research has segmented the market report on the basis of type of molecule, phase, route of administration, application, and region:

By Type of Molecule Outlook (Revenue, USD Billion, 2020-2034)

Small Molecules

Biologics

By Phase Outlook (Revenue, USD Billion, 2020-2034)

Phase I

Phase II

Phase I/II

Preclinical

By Route of Administration Outlook (Revenue, USD Billion, 2020-2034)

Oral

Intravenous

By Application Outlook (Revenue, USD Billion, 2020-2034)

Oncology

Hematology

Inflammatory and Metabolic Diseases

Neurology

Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global NAMPT Inhibitors Market Insights

  • 4.1. NAMPT Inhibitors Market - Market Snapshot
  • 4.2. NAMPT Inhibitors Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Supportive Regulatory and Funding Environment
      • 4.2.1.2. Increasing Global Cancer Burden
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Toxicity and Safety Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. NAMPT Inhibitors Market Trends
  • 4.6. Value Chain Analysis

5. Global NAMPT Inhibitors Market, by Type of Molecule

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • 5.3. Small Molecules
    • 5.3.1. Global NAMPT Inhibitors Market, by Small Molecules, by Region, 2020-2034 (USD Billion)
  • 5.4. Biologics
    • 5.4.1. Global NAMPT Inhibitors Market, by Biologics, by Region, 2020-2034 (USD Billion)

6. Global NAMPT Inhibitors Market, by Phase

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • 6.3. Phase I
    • 6.3.1. Global NAMPT Inhibitors Market, by Phase I, by Region, 2020-2034 (USD Billion)
  • 6.4. Phase II
    • 6.4.1. Global NAMPT Inhibitors Market, by Phase II, by Region, 2020-2034 (USD Billion)
  • 6.5. Phase I/II
    • 6.5.1. Global NAMPT Inhibitors Market, by Phase I/II, by Region, 2020-2034 (USD Billion)
  • 6.6. Preclinical
    • 6.6.1. Global NAMPT Inhibitors Market, by Preclinical, by Region, 2020-2034 (USD Billion)

7. Global NAMPT Inhibitors Market, by Route of Administration

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • 7.3. Oral
    • 7.3.1. Global NAMPT Inhibitors Market, by Oral, by Region, 2020-2034 (USD Billion)
  • 7.4. Intravenous
    • 7.4.1. Global NAMPT Inhibitors Market, by Intravenous, by Region, 2020-2034 (USD Billion)

8. Global NAMPT Inhibitors Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • 8.3. Oncology
    • 8.3.1. Global NAMPT Inhibitors Market, by Oncology, by Region, 2020-2034 (USD Billion)
  • 8.4. Hematology
    • 8.4.1. Global NAMPT Inhibitors Market, by Hematology, by Region, 2020-2034 (USD Billion)
  • 8.5. Inflammatory and Metabolic Diseases
    • 8.5.1. Global NAMPT Inhibitors Market, by Inflammatory and Metabolic Diseases, by Region, 2020-2034 (USD Billion)
  • 8.6. Neurology
    • 8.6.1. Global NAMPT Inhibitors Market, by Neurology, by Region, 2020-2034 (USD Billion)
  • 8.7. Others
    • 8.7.1. NAMPT Inhibitors Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global NAMPT Inhibitors Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. NAMPT Inhibitors Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 9.3. NAMPT Inhibitors Market - North America
    • 9.3.1. North America: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
    • 9.3.2. North America: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
    • 9.3.3. North America: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.3.4. North America: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.3.5. NAMPT Inhibitors Market - U.S.
      • 9.3.5.1. U.S.: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.3.5.2. U.S.: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.3.5.3. U.S.: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.3.5.4. U.S.: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.3.6. NAMPT Inhibitors Market - Canada
      • 9.3.6.1. Canada: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.3.6.2. Canada: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.3.6.3. Canada: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.3.6.4. Canada: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • 9.4. NAMPT Inhibitors Market - Europe
    • 9.4.1. Europe: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
    • 9.4.2. Europe: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
    • 9.4.3. Europe: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.4. Europe: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.4.5. NAMPT Inhibitors Market - UK
      • 9.4.5.1. UK: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.4.5.2. UK: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.4.5.3. UK: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.5.4. UK: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.4.6. NAMPT Inhibitors Market - France
      • 9.4.6.1. France: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.4.6.2. France: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.4.6.3. France: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.6.4. France: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.4.7. NAMPT Inhibitors Market - Germany
      • 9.4.7.1. Germany: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.4.7.2. Germany: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.4.7.3. Germany: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.7.4. Germany: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.4.8. NAMPT Inhibitors Market - Italy
      • 9.4.8.1. Italy: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.4.8.2. Italy: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.4.8.3. Italy: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.8.4. Italy: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.4.9. NAMPT Inhibitors Market - Spain
      • 9.4.9.1. Spain: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.4.9.2. Spain: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.4.9.3. Spain: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.9.4. Spain: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.4.10. NAMPT Inhibitors Market - Netherlands
      • 9.4.10.1. Netherlands: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.4.10.2. Netherlands: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.4.10.3. Netherlands: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.10.4. Netherlands: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.4.11. NAMPT Inhibitors Market - Russia
      • 9.4.11.1. Russia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.4.11.2. Russia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.4.11.3. Russia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.11.4. Russia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.4.12. NAMPT Inhibitors Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.4.12.2. Rest of Europe: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.4.12.3. Rest of Europe: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.4.12.4. Rest of Europe: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • 9.5. NAMPT Inhibitors Market - Asia Pacific
    • 9.5.1. Asia Pacific: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
    • 9.5.2. Asia Pacific: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
    • 9.5.3. Asia Pacific: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.4. Asia Pacific: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.5.5. NAMPT Inhibitors Market - China
      • 9.5.5.1. China: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.5.5.2. China: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.5.5.3. China: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.5.4. China: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.5.6. NAMPT Inhibitors Market - India
      • 9.5.6.1. India: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.5.6.2. India: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.5.6.3. India: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.6.4. India: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.5.7. NAMPT Inhibitors Market - Malaysia
      • 9.5.7.1. Malaysia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.5.7.2. Malaysia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.5.7.3. Malaysia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.7.4. Malaysia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.5.8. NAMPT Inhibitors Market - Japan
      • 9.5.8.1. Japan: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.5.8.2. Japan: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.5.8.3. Japan: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.8.4. Japan: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.5.9. NAMPT Inhibitors Market - Indonesia
      • 9.5.9.1. Indonesia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.5.9.2. Indonesia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.5.9.3. Indonesia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.9.4. Indonesia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.5.10. NAMPT Inhibitors Market - South Korea
      • 9.5.10.1. South Korea: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.5.10.2. South Korea: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.5.10.3. South Korea: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.10.4. South Korea: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.5.11. NAMPT Inhibitors Market - Australia
      • 9.5.11.1. Australia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.5.11.2. Australia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.5.11.3. Australia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.11.4. Australia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.5.12. NAMPT Inhibitors Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.5.12.2. Rest of Asia Pacific: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.5.12.3. Rest of Asia Pacific: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.5.12.4. Rest of Asia Pacific: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • 9.6. NAMPT Inhibitors Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
    • 9.6.2. Middle East & Africa: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
    • 9.6.3. Middle East & Africa: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.4. Middle East & Africa: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.6.5. NAMPT Inhibitors Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.6.5.2. Saudi Arabia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.6.5.3. Saudi Arabia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.5.4. Saudi Arabia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.6.6. NAMPT Inhibitors Market - UAE
      • 9.6.6.1. UAE: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.6.6.2. UAE: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.6.6.3. UAE: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.6.4. UAE: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.6.7. NAMPT Inhibitors Market - Israel
      • 9.6.7.1. Israel: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.6.7.2. Israel: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.6.7.3. Israel: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.7.4. Israel: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.6.8. NAMPT Inhibitors Market - South Africa
      • 9.6.8.1. South Africa: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.6.8.2. South Africa: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.6.8.3. South Africa: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.8.4. South Africa: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.6.9. NAMPT Inhibitors Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.6.9.2. Rest of Middle East & Africa: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.6.9.3. Rest of Middle East & Africa: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.6.9.4. Rest of Middle East & Africa: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • 9.7. NAMPT Inhibitors Market - Latin America
    • 9.7.1. Latin America: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
    • 9.7.2. Latin America: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
    • 9.7.3. Latin America: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.4. Latin America: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.7.5. NAMPT Inhibitors Market - Mexico
      • 9.7.5.1. Mexico: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.7.5.2. Mexico: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.7.5.3. Mexico: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.7.5.4. Mexico: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.7.6. NAMPT Inhibitors Market - Brazil
      • 9.7.6.1. Brazil: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.7.6.2. Brazil: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.7.6.3. Brazil: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.7.6.4. Brazil: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.7.7. NAMPT Inhibitors Market - Argentina
      • 9.7.7.1. Argentina: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.7.7.2. Argentina: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.7.7.3. Argentina: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.7.7.4. Argentina: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
    • 9.7.8. NAMPT Inhibitors Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
      • 9.7.8.2. Rest of Latin America: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
      • 9.7.8.3. Rest of Latin America: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
      • 9.7.8.4. Rest of Latin America: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. AbbVie Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Angelini Pharma S.p.A.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Antengene Therapeutics Limited
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Aqualung Therapeutics Corporation
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. AstraZeneca plc
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Bayer AG
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Boehringer Ingelheim GmbH
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Calico LLC
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. FORMA Therapeutics, Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Genentech, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. GlaxoSmithKline plc (GSK plc)
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Johnson & Johnson Services, Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development

List of Tables:

  • Table 1 Global NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 2 Global NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 3 Global NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 4 Global NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 5 North America: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 6 North America: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 7 North America: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 8 North America: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 9 U.S.: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 10 U.S.: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 11 U.S.: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 12 U.S.: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 13 Canada: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 14 Canada: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 15 Canada: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 16 Canada: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 17 Europe: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 18 Europe: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 19 Europe: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 20 Europe: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 21 UK: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 22 UK: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 23 UK: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 24 UK: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 25 France: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 26 France: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 27 France: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 28 France: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 29 Germany: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 30 Germany: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 31 Germany: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 32 Germany: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 33 Italy: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 34 Italy: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 35 Italy: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 36 Italy: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 37 Spain: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 38 Spain: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 39 Spain: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 40 Spain: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 41 Netherlands: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 42 Netherlands: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 43 Netherlands: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 44 Netherlands: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 45 Russia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 46 Russia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 47 Russia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 48 Russia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 49 Rest of Europe: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 50 Rest of Europe: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 51 Rest of Europe: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 52 Rest of Europe: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 53 Asia Pacific: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 54 Asia Pacific: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 55 Asia Pacific: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 56 Asia Pacific: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 57 China: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 58 China: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 59 China: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 60 China: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 61 India: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 62 India: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 63 India: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 64 India: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 65 Malaysia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 66 Malaysia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 67 Malaysia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 68 Malaysia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 69 Japan: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 70 Japan: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 71 Japan: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 72 Japan: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 73 Indonesia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 74 Indonesia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 75 Indonesia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 76 Indonesia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 77 South Korea: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 78 South Korea: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 79 South Korea: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 80 South Korea: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 81 Australia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 82 Australia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 83 Australia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 84 Australia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 85 Rest of Asia Pacific: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 86 Rest of Asia Pacific: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 87 Rest of Asia Pacific: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 88 Rest of Asia Pacific: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 89 Middle East & Africa: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 90 Middle East & Africa: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 91 Middle East & Africa: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 92 Middle East & Africa: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 93 Saudi Arabia: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 94 Saudi Arabia: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 95 Saudi Arabia: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 96 Saudi Arabia: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 97 UAE: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 98 UAE: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 99 UAE: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 100 UAE: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 101 Israel: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 102 Israel: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 103 Israel: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 104 Israel: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 105 South Africa: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 106 South Africa: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 107 South Africa: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 108 South Africa: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 109 Rest of Middle East & Africa: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 110 Rest of Middle East & Africa: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 111 Rest of Middle East & Africa: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 112 Rest of Middle East & Africa: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 113 Latin America: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 114 Latin America: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 115 Latin America: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 116 Latin America: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 117 Mexico: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 118 Mexico: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 119 Mexico: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 120 Mexico: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 121 Brazil: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 122 Brazil: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 123 Brazil: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 124 Brazil: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 125 Argentina: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 126 Argentina: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 127 Argentina: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 128 Argentina: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)
  • Table 129 Rest of Latin America: NAMPT Inhibitors Market, by Type of Molecule, 2020-2034 (USD Billion)
  • Table 130 Rest of Latin America: NAMPT Inhibitors Market, by Phase, 2020-2034 (USD Billion)
  • Table 131 Rest of Latin America: NAMPT Inhibitors Market, by Route of Administration, 2020-2034 (USD Billion)
  • Table 132 Rest of Latin America: NAMPT Inhibitors Market, by Application, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global NAMPT Inhibitors Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type of Molecule
  • Figure 7. Global NAMPT Inhibitors Market, by Type of Molecule, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Phase
  • Figure 9. Global NAMPT Inhibitors Market, by Phase, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Route of Administration
  • Figure 11. Global NAMPT Inhibitors Market, by Route of Administration, 2024 & 2034 (USD Billion)
  • Figure 12. Market by Application
  • Figure 13. Global NAMPT Inhibitors Market, by Application, 2024 & 2034 (USD Billion)